Despite some progress, too many people are still dying of advanced breast cancer (ABC) too early each year. The burden of the disease is expected to increase dramatically in the coming years with the developing world hit hardest. With the advances in science, technology and communication tools, it is imperative that the cancer community around the globe joins forces to raise awareness of the disease and lobby for better outcomes for people living with ABC.
The ABC Global Alliance, established by the European School of Oncology, is a multi-stakeholder platform for all those interested in collaborating on common projects relating to ABC. Launched at the World Cancer Congress in 2016, its goal is to improve and extend the lives of women and men living with ABC in all countries worldwide and to fight for a cure.
ABC Global Alliance held its first official meeting in Lisbon on 4 and 5 November immediately after the ABC4 Conference.
On behalf of everyone at the ABC Global Alliance, we would like to thank all participants that attended the meeting.
The ABC Global Alliance is an ESO initiative sponsored through unrestricted grants provided by AstraZeneca (Main Sponsor), Novartis (Main Sponsor), Pfizer (Main Sponsor) and Lilly (Sponsor).